RADventure attended the 2016 ECR conference at Vienna. We appreciate the quality of sessions we were able to join. Several speakers talked about the future of cancer screening, and they all had one topic in common: Personalized Screening. It was nice to see that our screening software solutions already anticipate and support these new developments. We had the opportunity to show our screening solutions to interested organizations / delegations. ECR 2016: a great way to learn and share information about radiology solutions in healthcare. RADventure was glad to be a part of this!
Cardiovascular diseases are the primary cause of morbidity and mortality in Europe. Early detection (screening) and treatment for cardiovascular diseases in large groups of people without symptoms (general population) might have the opportunity to reduce cardiovascular-related morbidity and mortality. However, evidence is lacking whether the benefits of screening (e.g. reduced morbidity and mortality) justify the potential harms (e.g. unnecessary treatment, costs).
The ROBINSCA (Risk Or Benefit IN Screening for Cardiovascular disease) is the only large-scale population-based randomized controlled trial that investigates the cost-effectiveness of screening for cardiovascular diseases. About 39,000 participants will be randomized to either the control arm (no screening), intervention arm A (risk calculation by means of well-known risk factors) or intervention group B (risk calculation by means of coronary artery calcium scoring (CT scan)). After five years, these groups will be compared regarding differences in cardiovascular-related morbidity and mortality.
Based on over 15 years of experience with preventative cancer screening projects, RADventure has built the software to manage the logistic flow of this research program. The ROBINSCA-system connects to the population registry in The Netherlands to obtain and synchronize data. It manages the status of almost 400,000 initial individuals through invitations and risk assessments, study enrollment, randomization, planning, invitation management and the data collection from laboratories and scan centers. It provides extensive functionality to conduct complex sample investigations related to individual milestones and provides multiple modalities to communicate with participants. The system provides intuitive two-way interfaces for anonymized statistical processing.
Beginning of March 2015, the first 5,196 participants were randomized and enrolled in the study.
The RADventure Group is specializing in supporting and managing preventative screening programs and established several ICT systems for both national and international screening programs since the year 2000.
ISO guarantees the customers and partners of the RADventure Group a continuous high quality of service with proven standards and a constant focus on improvement of services.
The certificate will be valid for 3 years and every year an external auditor of the certifying organization, TŪV Rheinland, will be validating our Quality System.
Petra van der Voort, Director Operations RADventure Group:
We are very happy and proud to announce to our customers and partners, we have earned the ISO 9001:2008 certificate at February 27th 2015. Herewith we are proving high quality and the reliability of our organization and our services. Thus we demonstrate to our customers and partners that we set high standards of quality of our IT systems. The RADventure Group is always aiming to deliver the best value and quality for money.
On the 17th of October RADventure attended the meeting of the Colorectal Cancer Screening Committee in Vienna. This committee is part of the World Endoscopy Organization (WEO). The sessions provided valuable information on screening methodologies, tests and equipment, substantiated with the outcomes of multiple scientific research programs. RADventure co-sponsored the event because of it’s added value to our product development. For more information, please visit: www.worldendo.org/
The RADventure Group is extremely proud to be the main ICT partner of the Dutch Breast Cancer Screening Program. According to the RIVM this program is one of the 15 Top Projects in Health Care. Please note that this article is in Dutch.
Projects: Topprojecten van het RIVM
Healthcare programs, like nationwide Population Screening, are a serious topic in the EMEA Region. There are various initiatives in many countries within this region that are continuously improving the already very high Healthcare standards.
The RADventure Group is proud to be part of these improvements. Our Screening Consultants are very welcome expert partners for countries in the EMEA region when it comes to developing and implementing innovative and effective screening programs. They are being asked to support brainstorm sessions and besides their comprehensive ICT knowledge they add value in designing and managing the process flows within a screening program.
For over 20 years we are one of the expert suppliers of the Dutch government in the national screening programs like breast cancer, colon cancer and cervical cancer together with Philips Healthcare, Tromp Medical and the Dutch Reference Center for Screening (LRCB). Next to that our ICT programs are running at the Caribbean and the Spanish government is implementing the breast cancer screening (BCS System) together with RADventure and Philips Spain on the Canary Islands.
Reinaerdt Deuren B.V. started a project to completely renew its sales IT system. Key to the development is a high level web based graphical interface: before the manufacturing process starts, custom made doors can be designed and calculated in an extremely user friendly environment. Through the new system Reinaerdt Deuren will also be able to track and trace all related sales activities.
It is an explicit requirement to deliver the system in a short time frame and the RADventure .NET Software Team started the project in May 2014 using Agile as a development methodology. The collaboration between Reinardt Deuren and the RADventure Group started 14 years ago and ever since we develop and maintain the Reinaerdt Deuren sales IT system.
Reinaerdt Deuren is an innovative company that manufactures high quality doors in an explicitly sustainable process. Reinaerdt Deuren gains competitive edge through a high-technology IT infrastructure covering all working processes. The doors are produced fully computer-controlled, both for large industrial projects as well as utility projects. The company has a broad international focus, maintains factories in the Netherlands and Germany and has a significant market share in the UK.
RADventure started the development of the ROBINSCA system, working with the Erasmus MC (Rotterdam) to support the ROBINSCA trial.
The purpose of this research project is to investigate whether the early detection of an increased risk for cardiovascular disease followed by adequate treatment will reduce cardiovascular related morbidity and mortality. Over 330.000 people of the general population will be addressed to participate. About 39.000 people with an expected increased risk will be randomly assigned to one of the three groups for risk analysis (control versus classical risk factors versus Coronary Artery Calcium score), that will be compared after a follow up period of 5 to 10 years.
The contract was assigned to RADventure in March 2014, based on our experience with screening and screening related research programs.
For more information please visit: http://www.gezondheidsraad.nl/en/publications/prevention/population-screening-act-calcium-score-and-risk-cardiovascular-disease
We are very excited to have launched our new website!
The website has improved functionality, design and navigation and is more aligned with the RADventure Group strategic vision for growth and expansion in both national and international markets.
The New website includes extensive product information, available services and the latest news.
3542 DP Utrecht
(+31) (0)88 77 647 47
Daily: 8.30AM to 5.30PM CET
Copyright RADventure 2021 © All Rights Reserved